Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats

A novel µ-opioid receptor antagonist, methocinnamox (MCAM), attenuates some abuse-related and toxic effects of opioids. This study further characterized the pharmacology of MCAM in separate groups of rats using procedures to examine antinociception, gastrointestinal motility, and withdrawal in morph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pharmacol Exp Ther
Autors principals: Gerak, Lisa R., Minervini, Vanessa, Latham, Elizabeth, Ghodrati, Saba, Lillis, Katherine V., Wooden, Jessica, Disney, Alex, Husbands, Stephen M., France, Charles P.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Pharmacology and Experimental Therapeutics 2019
Matèries:
Behavioral Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6863459/
https://ncbi.nlm.nih.gov/pubmed/31439807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.119.260331
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars